in order to study the pathogenesis of adenocarcinoma and to determine the frequency of adenosis following prenatal exposure to des , timed pregnant cd-1 mice were treated s.c. with des ( dose range , 5 to 100 micrograms/kg/day ) on days 9 though 16 of gestation .
C0012203
des
C0032961
gestation